ATE287713T1 - Verwendung von riluzol zur behandlung multipler sklerose - Google Patents
Verwendung von riluzol zur behandlung multipler skleroseInfo
- Publication number
- ATE287713T1 ATE287713T1 AT00939007T AT00939007T ATE287713T1 AT E287713 T1 ATE287713 T1 AT E287713T1 AT 00939007 T AT00939007 T AT 00939007T AT 00939007 T AT00939007 T AT 00939007T AT E287713 T1 ATE287713 T1 AT E287713T1
- Authority
- AT
- Austria
- Prior art keywords
- riluzole
- multiple sclerosis
- treat multiple
- treat
- benzothiazolamine
- Prior art date
Links
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 3
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 229960004181 riluzole Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99201788 | 1999-06-04 | ||
| US17432800P | 2000-01-04 | 2000-01-04 | |
| PCT/IB2000/000933 WO2000074676A1 (en) | 1999-06-04 | 2000-06-02 | Use of riluzole for the treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE287713T1 true ATE287713T1 (de) | 2005-02-15 |
Family
ID=56290027
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00939007T ATE287713T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
| AT05001476T ATE419851T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05001476T ATE419851T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1187612B1 (enExample) |
| JP (1) | JP2003522121A (enExample) |
| AT (2) | ATE287713T1 (enExample) |
| AU (1) | AU777537B2 (enExample) |
| CA (1) | CA2375874A1 (enExample) |
| DE (1) | DE60017733T2 (enExample) |
| ES (1) | ES2235896T3 (enExample) |
| NZ (1) | NZ515685A (enExample) |
| PT (1) | PT1187612E (enExample) |
| SI (1) | SI1187612T1 (enExample) |
| WO (1) | WO2000074676A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000001376A2 (en) | 1998-07-02 | 2000-01-13 | Eisai Co., Ltd | Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| IL136687A0 (en) * | 2000-06-12 | 2001-06-14 | Mor Research Applic Ltd | Pharmaceutical composition for the treatment of multiple sclerosis |
| WO2005084377A2 (en) * | 2004-03-03 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Combination therapy with glatiramer acetate and riluzole |
| ITMI20061274A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Vettori nanoparticellari lipidici contenenti riluzolo e composizioni farmaceutiche che li contengono |
| EP2228054A1 (en) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
| WO2010113225A1 (en) * | 2009-03-30 | 2010-10-07 | Yutoku Pharmaceutical Industries Co., Ltd. | Riluzole-containing transdermal patch |
| AU2015350142A1 (en) * | 2014-11-21 | 2017-06-15 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual administration of riluzole |
| JP6827924B2 (ja) * | 2014-11-26 | 2021-02-10 | メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． | イブジラスト及びリルゾールの組み合わせを含む医薬および組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
| AU7298196A (en) * | 1995-10-25 | 1997-05-15 | Janssen Pharmaceutica N.V. | Infusions of neuroprotectants and perfluorochemicals |
| US6133258A (en) * | 1995-11-05 | 2000-10-17 | Yamanouchi Pharmaceutical Co., Ltd. | Inhibitor of kainic acid neurotoxicity and pyridothiazine derivative |
| US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
| IL119989A0 (en) * | 1997-01-10 | 1997-04-15 | Yeda Res & Dev | Pharmaceutical compositions for oral treatment of multiple sclerosis |
| JP4120713B2 (ja) * | 1997-09-04 | 2008-07-16 | 大塚製薬株式会社 | 多発性硬化症治療剤 |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
-
2000
- 2000-06-02 DE DE60017733T patent/DE60017733T2/de not_active Expired - Lifetime
- 2000-06-02 EP EP00939007A patent/EP1187612B1/en not_active Expired - Lifetime
- 2000-06-02 JP JP2001501213A patent/JP2003522121A/ja active Pending
- 2000-06-02 CA CA002375874A patent/CA2375874A1/en not_active Abandoned
- 2000-06-02 AT AT00939007T patent/ATE287713T1/de active
- 2000-06-02 AT AT05001476T patent/ATE419851T1/de not_active IP Right Cessation
- 2000-06-02 EP EP05001476A patent/EP1552831B1/en not_active Expired - Lifetime
- 2000-06-02 SI SI200030601T patent/SI1187612T1/xx unknown
- 2000-06-02 ES ES00939007T patent/ES2235896T3/es not_active Expired - Lifetime
- 2000-06-02 AU AU54219/00A patent/AU777537B2/en not_active Ceased
- 2000-06-02 PT PT00939007T patent/PT1187612E/pt unknown
- 2000-06-02 NZ NZ515685A patent/NZ515685A/xx not_active IP Right Cessation
- 2000-06-02 WO PCT/IB2000/000933 patent/WO2000074676A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1187612B1 (en) | 2005-01-26 |
| DE60017733D1 (de) | 2005-03-03 |
| NZ515685A (en) | 2002-12-20 |
| WO2000074676A1 (en) | 2000-12-14 |
| JP2003522121A (ja) | 2003-07-22 |
| EP1552831B1 (en) | 2009-01-07 |
| DE60017733T2 (de) | 2006-01-12 |
| EP1552831A1 (en) | 2005-07-13 |
| ATE419851T1 (de) | 2009-01-15 |
| EP1187612A1 (en) | 2002-03-20 |
| SI1187612T1 (en) | 2005-06-30 |
| PT1187612E (pt) | 2005-05-31 |
| AU5421900A (en) | 2000-12-28 |
| AU777537B2 (en) | 2004-10-21 |
| ES2235896T3 (es) | 2005-07-16 |
| CA2375874A1 (en) | 2000-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE313326T1 (de) | VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß | |
| ATE201138T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose | |
| ATE480235T1 (de) | Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose | |
| DE69910368D1 (de) | Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen | |
| ATE304350T1 (de) | Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen | |
| EP1487877A4 (en) | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS | |
| DE69941566D1 (de) | N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie | |
| ATE179610T1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
| ZA200309808B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| DE69532804D1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| ATE362374T1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE69840752D1 (de) | Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen | |
| DE69937624D1 (de) | Verfahren zur Behandlung von Metalloberflächen | |
| DE59707519D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
| ATE419851T1 (de) | Verwendung von riluzol zur behandlung multipler sklerose | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| ATE353667T1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60041365D1 (de) | Verwendung von Riluzol zur Behandlung Multipler Sklerose | |
| DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| ATE281165T1 (de) | Verwendung von pramipexol zur behandlung von restless-legs-syndrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1187612 Country of ref document: EP |